Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Ambagon Therapeutics

Ambagon Therapeutics

Series A
Eindhoven, NetherlandsJan 2022
Healthtech

Ambagon Therapeutics raised €75M in a Series A round in Jan 2022. The company is based in Eindhoven, Netherlands. Investors in the round: AbbVie Ventures, Droia Ventures, INKEF Capital and 5 others. Data as of Nov 2026.

← Ambagon Therapeutics
Amount raised
€75M
€75,234,555
Native amount
85,000,000 USD
Stage
Series A
series a
Investors
8

Provenance & confidence

High confidence
Amount
85,000,000 USD
ECB-at-date → €75M · rate 1.1298 on 2022-01-07
High confidence
Source

siliconcanals.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

8 named
AbbVie VenturesDroia VenturesINKEF CapitalMission BioCapitalMRL Ventures FundNextech InvestRA Capital ManagementSurveyor Capital
Date
Jan 2022
Round type
series a
Amount (EUR)
€75M

Other rounds

same company

This is the company's only recorded round.

Related news